B-type natriuretic peptide (BNP) in HCV-positive Egyptian patients: the impact of HCV eradication on plasma BNP levels

B-type natriuretic peptide (BNP) in HCV-positive Egyptian patients: the impact of HCV eradication on plasma BNP levels

Abstract Background Chronic hepatitis C virus (HCV) infection represents a major health-related burden in Egypt. HCV is considered as a major cardiovascular risk factor. BNP (B-type natriuretic peptide) has been determined as a credible diagnostic and prognostic cardiac biomarker. We aimed to assess...

Full description

Bibliographic Details
Main Authors: Ali Nada, Aliaa Sabry, Naglaa S. Elabd, Azza M. Abdu Allah, Nada Elnaidany, Mohamed Abbasy
Format: Article
Language:English
Published: SpringerOpen 2021-07-01
Series:Egyptian Liver Journal
Subjects:
BNP
HCV Patients
DAAs therapy
Online Access:https://doi.org/10.1186/s43066-021-00133-4

Internet

https://doi.org/10.1186/s43066-021-00133-4

Similar Items